Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Stock (NASDAQ: DTIL) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.950 - 5.200 | Open / Close- / - | Float / Outstanding106.799M / 110.959M |
Vol / Avg.0 / 574.401K | Mkt Cap128.712M | P/E- | 50d Avg. Price1.240 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float106.799M | EPS-1.420 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-14 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.260 | -0.220 | 0.0400 | ||||
REV | 5.970M | 7.363M | 1.393M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precision BioSciences (NASDAQ: DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Fusion Pharmaceuticals (NASDAQ:FUSN), Sesen Bio (NASDAQ:SESN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 1.00 expecting DTIL to fall to within 12 months (a possible -13.79% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $1.16 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences’s Q4 earnings are confirmed for Tuesday, March 14, 2023.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.